“Everyone has a role to play when thinking about patient value. It takes the entire healthcare ecosystem coming together and each playing their part to bring patient-centered value to the forefront.”

Shelby Harrington

Managing Director

AMCP Nexus 2022

AMCP Nexus 2022 will take place October 11–14 in National Harbor, MD. Join Avalere experts Sarah Alwardt and Shelby Harrington for a panel discussion on the evolution to patient-centric value frameworks, their utility to different stakeholders, and how they can be used as a mechanism to drive the transformation to a patient-centered, equitable health system:

“ Patient-Centric Value Frameworks: Evolving from an Economic to a Holistic Evaluation,” on Wednesday, October 12, 1:00–2:15 PM ET.

Meet Our
Experts

We will be available at AMCP Nexus 2022. Click the button to the right to set up a time to meet with us to see how Avalere can help your business.

Connect with an Expert

Sarah Alwardt

Practice Director, Healthcare Transformation

Expertise: Real-world evidence, non-traditional evidence generation, strategy, research, operations, technology innovation

Michael Ciarametaro

Principal, Policy

Expertise: Value and evidence strategy, policy, health technology assessment, value-based pricing and contracting, government drug price regulation, payment reform

Shelby Harrington, RN

Principal, Healthcare Transformation

Expertise: Quality improvement, clinical strategy, digital transformation, value analytics

John C. Neal

Managing Director, Market Access

Expertise: Market access, launch strategy, novel therapies

Milena Sullivan

Managing Director, Policy

Expertise: Federal health policy, Medicare policy and payment, state policy advocacy, strategy

Our experts will be available to discuss these priority topics

Patient-Centric Evidence Development

Payers and providers are demanding non-traditional evidence to answer questions about how different types of patients fare in real-world settings. Avalere experts can draw on their experience fostering meaningful conversations among disparate group to leverage patient experiences to enhance patient experiences and outcome.

Part D Redesign and Strategy

Avalere‘s market access and policy experts can help clients understand questions related to the implementation of the Inflation Reduction Act’s (IRA) drug pricing policies; conduct tailored modeling of the financial impact of Part D redesign, inflation rebates, and Medicare negotiation; and forecast likely stakeholder responses to IRA policies and impact on formulary negotiations.

Value in a Fragmented World

The IRA adds to an increasingly sophisticated and fragmented value ecosystem. Avalere experts are well positioned to help clients meet diverse and evolving requirements ranging from government negotiation to the Institute for Clinical and Economic Review (ICER).